Posted in Uncategorized on January 2, 2016| Leave a Comment »
Download the Book: Antihypertensive Drugs PDF For Free, Preface: Hypertension, known as a “silent killer” is widely prevalent and a major risk factor for…
Sourced through Scoop.it from: am-medicine.com
See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Posted in Innovations in Neurophysiology & Neuropsychology on January 2, 2016| Leave a Comment »
Reporter: Aviva Lev-Ari, PhD, RN
Prescription painkillers, antidepressants and other brain drugs have gender-specific effects
Sourced through Scoop.it from: www.scientificamerican.com
See on Scoop.it – Cardiotoxicity
Posted in Uncategorized on January 2, 2016| Leave a Comment »
Background Physical activity is recommended as a part of a comprehensive lifestyle approach in the treatment of hypertension, but there is a lack of data about the relationship between different intensities of physical activity and cardiovascular…
Sourced through Scoop.it from: journals.plos.org
See on Scoop.it – Cardiotoxicity
Posted in Deep Learning, Machine Learning, Natural Language Processing (NLP) on January 2, 2016| Leave a Comment »
Best of 2015: Deep Learning Machine Beats Humans in IQ Test | MIT Technology Review
Reporter: Aviva Lev-Ari, PhD, RN
Computers have never been good at answering the type of verbal reasoning questions found in IQ tests. Now a deep learning machine unveiled in China is changing that. From June …
Sourced through Scoop.it from: www.technologyreview.com
Posted in Uncategorized on January 2, 2016| Leave a Comment »
Artificial intelligence is changing not only the way we use our computers and smartphones but the way we interact with the real world.
Sourced through Scoop.it from: www.wired.com
Posted in BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, tagged gene biology, gene sequencing, genetics, genomics, Harvard, MIT on January 2, 2016| Leave a Comment »
Reported by: Irina Robu
Vassar Street and Main Street, in the new world’s Cambridge, Massachusetts, would be a leading candidate.
According to the article published in Wired Magazine in November 2015 “when the Whitehead got too small for genomicist Eric Lander’s ambitions, he launched a flashier and brasher newcomer next door. The Broad Institute’s gargantuan gleaming glass lobby is filled with early gene-sequencing instruments. Its multimedia screens boast that this is one of the world’s largest gene-sequencing and research factories. The Broad’s strategy is different from that of the Whitehead; instead of concentrating a few in an ultra-exclusive bioclub, Broad bridges MIT, Harvard and most of the hospitals in Boston. Its 2,000 members extend outwards, partnering with tens of thousands of others globally. Those working at the Broad are not averse to commerce; its director alone helped to build Foundation Medicine, Verastem, Millennium, Fidelity Biosciences, Courtagen and Aclara among many other leading companies.
The sixth building on this extraordinary corner, Novartis, focuses on private research, and represents a huge migration from Basel in Switzerland towards the MIT campus, becoming Cambridge’s largest employer. Pfizer, Sanofi, Amgen, Biogen-Idec and hundreds of others cluster nearby. “
Source
2012pharmaceutical
sjwilliamspa